TherapeuticsMD Inc (TXMD): Net earnings per share growth forecast for next year

Public company logo of TherapeuticsMD, Inc. (TXMD)

The forward-looking EPS growth consensus forecast presented on GURU.Markets, this chart reveals the TherapeuticsMD, Inc. (TXMD) strategy to monetize patents through royalties without logistics costs. The current value of 0.00 represents the metric level amid the minimization of in-house R&D development. The company's growth relies on the marketing efficiency of partners in the hormone therapy sector and the optimization of debt obligations.

TXMD - TherapeuticsMD Inc Projected earnings per share increase next year over the range 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for TherapeuticsMD Corp (TXMD)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company valuation:therapeuticsmd.com, TXMD
Finished products of TherapeuticsMD Inc

Stable sales of women's health products at TherapeuticsMD, Inc. (TXMD) create the foundation for the expected growth dynamics of net earnings per share next year. This indicator measures the percentage change in projected earnings per share (EPS) relative to the current period, aggregating current assessments from US analysts. The positive trend confirms market confidence in the business's scalability, although overly optimistic expectations may mask risks of declining asset liquidity.